Evidence map›Paper›PMID 36909473›Full record

ArticlebioRxiv : the preprint server for biology2023

Whole genome sequencing of

Jacob E Lemieux, Weihua Huang, Nathan Hill, Tjasa Cerar, Lisa Freimark, Sergio Hernandez, Matteo Luban, Vera Maraspin, Petra Bogovic, Katarina Ogrinc and 15 more

Open access · greenFull text readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 2 countries.

Jacob E LemieuxMassachusetts General Hospital, Harvard Medical School.
Weihua HuangNew York Medical College.
Nathan HillMassachusetts General Hospital, Harvard Medical School.
Tjasa CerarUniversity of Ljubljana.
Lisa FreimarkBroad Institute of MIT and Harvard.
Sergio HernandezWadsworth Center.
Matteo LubanMassachusetts General Hospital, Harvard Medical School.
Vera MaraspinUniversity Medical Center Ljubljana.
Petra BogovicUniversity Medical Center Ljubljana.
Katarina OgrincUniversity Medical Center Ljubljana.
Eva Ruzic-SabljicUniversity of Ljubljana.
Pascal LapierreWadsworth Center.
Erica Lasek-NesselquistWadsworth Center.
Navjot SinghWadsworth Center.
Radha IyerNew York Medical College.
Dionysios LiverisNew York Medical College.
Kurt D ReedUniversity of Wisconsin.
John M LeongTufts University, Department of Molecular Biology and Microbiology.
John A BrandaMassachusetts General Hospital, Harvard Medical School.
Allen C SteereMassachusetts General Hospital, Harvard Medical School.
Gary P WormserNew York Medical College.
Franc StrleUniversity Medical Center Ljubljana.
Pardis C SabetiMassachusetts General Hospital, Harvard Medical School.
Ira SchwartzNew York Medical College.
Klemen StrleMassachusetts General Hospital, Harvard Medical School.
Broad Institute · USNew York Medical College · USWadsworth Center · USLjubljana University Medical Centre · SIHarvard University · USUniversity of Ljubljana · SITufts University · US

Funding

Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI CUOMO, CHRISTINA A · 2014 to 2024
$66.5M
West African Emerging Infectious Disease Research Center (WA-EIDRC)U01AI151812 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ANDERSEN, KRISTIAN GRAUGAARD, GARRY, ROBERT F · 2020 to 2024
$13.2M
DETERMINANTS OF B BURGDORFERI HEMATOGENOUS DISSEMINATIONR01AI045801 · NIAID · NEW YORK MEDICAL COLLEGE · PI SCHWARTZ, IRA S. · 1999 to 2015
$4.9M
NUCLEIC ACID-BASED DIANOSTIC PROBES FOR LYME DISEASER01AR041511 · NIAMS · NEW YORK MEDICAL COLLEGE · PI SCHWARTZ, IRA S. · 1991 to 2009
$4.1M
Defining Host Genetic Factors in Adverse Clinical Outcomes in Lyme DiseaseR21AI144916 · NIAID · WADSWORTH CENTER · PI LIN, YI-PIN, STRLE, KLEMEN · 2019 to 2020
$449k
Defining Microbial and Host Factors in Innate Immune Responses in Lyme ArthritisK01AR062098 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI STRLE, KLEMEN · 2012 to 2014
$398k
NIAID NIH HHS R01 AI045801NIAID NIH HHS R21 AI144916NIAID NIH HHS U01 AI151812NIAID NIH HHS U19 AI110818NIAMS NIH HHS K01 AR062098NIAMS NIH HHS R01 AR041511
6 · The paper itself

Abstract

Lyme disease is the most common vector-borne disease in North America and Europe. The clinical manifestations of Lyme disease vary based on the genospecies of the infecting

Identifiers

PMID36909473
PMCPMC10002713
OpenAlexW4322489234

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read56
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.